Balatucal, Baby Boy .
HRN: 23-77-56 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/27/2023
GENTAMICIN 40MG/ML, 2ML (AMP)
09/27/2023
10/04/2023
IV
12mg
Q24h
Potential Septic Newborn
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes